531762 UNJHAFOR

Unjha Formulations Share Price

₹28.50 +1.1 (4.01%)

24 Nov, 2024 11:47

SIP TrendupStart SIP in UNJHAFOR

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month -2.33%
  • Over 3 Month + 3.11%
  • Over 6 Month -10.41%
  • Over 1 Year + 73.57%
SIP Lightning

Smart Investing Starts Here Start SIP with Unjha Formulations for Steady Growth!

Invest Now

Unjha Formulations Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Unjha Formulations Financials

Unjha Formulations Technicals

EMA & SMA

Current Price
₹28.50
+ 1.1 (4.01%)
pointer
  • stock-down_img
  • Bullish Moving Average 7
  • stock-up_img
  • Bearish Moving Average 9
  • 20 Day
  • ₹30.01
  • 50 Day
  • ₹29.63
  • 100 Day
  • ₹28.14
  • 200 Day
  • ₹25.36

Resistance and Support

27.86 Pivot Speed
  • R3 29.85
  • R2 29.25
  • R1 28.46
  • S1 27.07
  • S2 26.47
  • S3 25.68

What's your outlook on Unjha Formulations?

You can only vote for once

Unjha Formulations Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-08 Quarterly Results
2024-08-01 Quarterly Results
2024-05-17 Audited Results
2024-03-29 Others
2024-01-29 Quarterly Results

Unjha Formulations F&O

Unjha Formulations Shareholding Pattern

No data available.

About Unjha Formulations

  • NSE Symbol
  • UNJHAFOR
  • BSE Symbol
  • 531762
  • ISIN
  • INE576D01015

Similar Stocks to Unjha Formulations

Unjha Formulations FAQs

Unjha Formulations share price is ₹28 As on 24 November, 2024 | 11:33

The Market Cap of Unjha Formulations is ₹12.8 Cr As on 24 November, 2024 | 11:33

The P/E ratio of Unjha Formulations is 15.9 As on 24 November, 2024 | 11:33

The PB ratio of Unjha Formulations is 4.7 As on 24 November, 2024 | 11:33

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23